Related Experiment Video
Updated: Jun 4, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Compilation of cost-effectiveness evidence for different heart conditions and treatment strategies
Nathalie Eckard1, Magnus Janzon, Lars-Åke Levin
1Center for Medical Technology Assessment, Division of Health Care Analysis, Linköping University, Sweden. nathalie.eckard@liu.se
Insights
This study compiles cost-effectiveness ratios for heart disease treatments, offering practical data for resource allocation. The findings aid decision-makers in optimizing cardiovascular healthcare investments.
Area of Science:
- Health Economics
- Cardiovascular Medicine
- Public Health Policy
Background:
- Limited accessible data exists on the cost-effectiveness of cardiovascular disease treatments.
- Decision-makers require practical economic evidence for resource allocation in cardiology.
- Health economic research is crucial for managing scarce healthcare resources.
Purpose of the Study:
- To present comprehensive cost-effectiveness ratios for heart disease treatments.
- To create a practical data set for cardiovascular healthcare decision-makers.
- To facilitate informed resource allocation in the cardiovascular field.
Main Methods:
- Systematic literature search for cost-effectiveness analyses of cardiovascular interventions.
- Compilation of cost-effectiveness ratios (cost per Quality Adjusted Life Year or life year gained).
- Categorization of data into a readily available cost-effectiveness ranking table by disease group.
Main Results:
- Cost-effectiveness ratios varied widely, from dominant (cost-saving) to over 1,000,000 Euros per Quality Adjusted Life Year gained.
- A categorized table of cost-effectiveness ratios and bibliographic references was generated.
- The data covers various heart conditions and treatment strategies.
Conclusions:
- Cost-effectiveness ranking tables effectively present health economic evidence.
- This compilation provides valuable, concise information for healthcare resource allocation decisions.
- The study offers an extensive overview of health economic evidence for cardiovascular disease treatment.
Objectives:
Despite the continuing interest in health economic research, we could find no accessible data set on cost-effectiveness, useful as practical information to decision makers who must allocate scarce resources within the cardiovascular field. The aim of this paper was to present cost-effectiveness ratios, based on a systematic literature search for the treatment of heart diseases.
Design:
A comprehensive literature search on cost-effectiveness analyses of intervention strategies for the treatment of heart diseases was conducted. We compiled available cost-effectiveness ratios for different heart conditions and treatment strategies, in a cost-effectiveness ranking table. The cost-effectiveness ratios were expressed as a cost per quality adjusted life year (QALY) or life year gained.
Results:
Cost-effectiveness ratios, ranging from dominant to those costing more than 1,000,000 Euros per QALY gained, and bibliographic references are provided for. The table was categorized according to disease group, making the ranking table readily available.
Conclusions:
Cost-effectiveness ranking tables provide a means of presenting cost-effectiveness evidence. They provide valid information within a limited space aiding decision makers on the allocation of health care resources. This paper represents an extensive compilation of health economic evidence for the treatment of heart diseases.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Heart Failure V: Medical Management
Hazard Ratio
For example, in a clinical trial evaluating a...
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
